Also found in: Medical.
HMPAOTc-Hexamethylpropyleneamine Oxime (radiophamaceutical tracer compound)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(b, f) SPECT-CT with HMPAO radiotracer on the area of the brain implant.
Imaging of mild traumatic brain injury using 57CO and [sup.99m]Tc HMPAO SPECT as compared to other diagnostic procedures.
rCBF measurements determined by HMPAO SPECT are deined in a relative (rather than absolute) fashion and are determined by assessing the difference in proportional compound uptake between a region of interest (vasospasm) and an arbitrarily selected "normal" region, usually the cerebellum or contralateral hemisphere [1, 10, 57](Figure 7).
The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression.
Objective: To determine an association between chronic tobacco use and changes in cerebral perfusion through semi-quantitative scintigraphic assessment employing metastable Technetium-99 labelled hexa-methyl propylene amine oxime single photon emission computed tomography (Tc-99m HMPAO SPECT).
In order to determine how regional cerebral blood flow would change during standing position in patients with idiopathic orthostatic hypotension, Tc-99m HMPAO SPECT studies were performed during postural testing in five patients.
Ga-67 and Tc-99m HMPAO labeled WBC imaging in erythema nodosum leprosum reaction of leprosy.
[sup.99m]TC-hexamethylpropylene amine oxime (HMPAO)-labeled leukocytes are often preferred for imaging inflammation, despite the relatively complex and time-consuming labeling procedure.
The results, obtained using Tc-99m HMPAO SPECT scans, also showed similarities between chronic fatigue syndrome and fibromyalgia.
Hexamethylpropylene amine oxime (HMPAO), or Ceretec[R], was the first radio-pharmaceutical used routinely for ictac SPECTs.